The Moderate-to-Severe Plaque Psoriasis Research Study (Up to 82 Weeks)

The Moderate-to-Severe Plaque Psoriasis Research Study (Up to 82 Weeks)

Study Summary

Who Can Participate?
Adults 18 to 79 years of age with moderate to severe plaque psoriasis may be eligible to participate.

Inclusion Criteria

  • Have stable chronic plaque psoriasis (with or without psoriatic arthritis) for at least 6 months
  • Moderate-to-severe plaque psoriasis, affecting 10% or more of the body (i.e. 10 handprints)
  • Don’t have non-plaque types of psoriasis or drug-induced psoriasis

Participant Information

  • Participate and receive study treatment at no cost
  • Regular visits with study doctors who specialize in treating plaque psoriasis
  • Will receive either an investigational injection treatment (active study drug) or a placebo
  • Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

  • Participation will last up to 82 weeks and involve about 15 visits to the study research site.
Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial